Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Barrier Therapeutics nets $68mm with IPO

Executive Summary

Dermatology drug company Barrier Therapeutics has netted about $68mm with a 5mm common share IPO priced at $15 a share, about the midpoint of its anticipated range. When the company originally filed in February, it was looking to raise $83.6mm.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies